Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
Quantitative analysis of dynamic .

EJNMMI research

Coello C, Fisk M, Mohan D, Wilson FJ, Brown AP, Polkey MI, Wilkinson I, Tal-Singer R, Murphy PS, Cheriyan J, Gunn RN.
PMID: 28547129
EJNMMI Res. 2017 Dec;7(1):47. doi: 10.1186/s13550-017-0291-2. Epub 2017 May 25.

BACKGROUND: An inflammatory reaction in the airways and lung parenchyma, comprised mainly of neutrophils and alveolar macrophages, is present in some patients with chronic obstructive pulmonary disease (COPD). Thoracic fluorodeoxyglucose (RESULTS: The qABL method detected no difference (Hedge's g...

Cite
Coello C, Fisk M, Mohan D, et al. Quantitative analysis of dynamic . EJNMMI Res. 2017;7(1):47doi: 10.1186/s13550-017-0291-2.
Coello, C., Fisk, M., Mohan, D., Wilson, F. J., Brown, A. P., Polkey, M. I., Wilkinson, I., Tal-Singer, R., Murphy, P. S., Cheriyan, J., & Gunn, R. N. (2017). Quantitative analysis of dynamic . EJNMMI research, 7(1), 47. https://doi.org/10.1186/s13550-017-0291-2
Coello, Christopher, et al. "Quantitative analysis of dynamic ." EJNMMI research vol. 7,1 (2017): 47. doi: https://doi.org/10.1186/s13550-017-0291-2
Coello C, Fisk M, Mohan D, Wilson FJ, Brown AP, Polkey MI, Wilkinson I, Tal-Singer R, Murphy PS, Cheriyan J, Gunn RN. Quantitative analysis of dynamic . EJNMMI Res. 2017 Dec;7(1):47. doi: 10.1186/s13550-017-0291-2. Epub 2017 May 25. PMID: 28547129; PMCID: PMC5445063.
Copy Download .nbib Format: NLM
Nutrition and health technology assessment: when two worlds meet.

Frontiers in pharmacology

Poley MJ.
PMID: 26539116
Front Pharmacol. 2015 Oct 20;6:232. doi: 10.3389/fphar.2015.00232. eCollection 2015.

There is a growing recognition that nutrition may have a positive impact on public health and that it may reduce medical expenditures. Yet, such claims need to be substantiated by evidence. This evidence could be delivered by health technology...

Cite
Poley MJ. Nutrition and health technology assessment: when two worlds meet. Front Pharmacol. 2015;6:232doi: 10.3389/fphar.2015.00232.
Poley, M. J. (2015). Nutrition and health technology assessment: when two worlds meet. Frontiers in pharmacology, 6232. https://doi.org/10.3389/fphar.2015.00232
Poley, Marten J. "Nutrition and health technology assessment: when two worlds meet." Frontiers in pharmacology vol. 6 (2015): 232. doi: https://doi.org/10.3389/fphar.2015.00232
Poley MJ. Nutrition and health technology assessment: when two worlds meet. Front Pharmacol. 2015 Oct 20;6:232. doi: 10.3389/fphar.2015.00232. eCollection 2015. PMID: 26539116; PMCID: PMC4611967.
Copy Download .nbib Format: NLM
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo.

Journal of cachexia, sarcopenia and muscle

Patel MS, Lee J, Baz M, Wells CE, Bloch S, Lewis A, Donaldson AV, Garfield BE, Hopkinson NS, Natanek A, Man WD, Wells DJ, Baker EH, Polkey MI, Kemp PR.
PMID: 27239406
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48. doi: 10.1002/jcsm.12096. Epub 2015 Dec 29.

BACKGROUND: Loss of muscle mass is a co-morbidity common to a range of chronic diseases including chronic obstructive pulmonary disease (COPD). Several systemic features of COPD including increased inflammatory signalling, oxidative stress, and hypoxia are known to increase the...

Cite
Patel MS, Lee J, Baz M, et al. Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. J Cachexia Sarcopenia Muscle. 2015;7(4):436-48doi: 10.1002/jcsm.12096.
Patel, M. S., Lee, J., Baz, M., Wells, C. E., Bloch, S., Lewis, A., Donaldson, A. V., Garfield, B. E., Hopkinson, N. S., Natanek, A., Man, W. D., Wells, D. J., Baker, E. H., Polkey, M. I., & Kemp, P. R. (2016). Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. Journal of cachexia, sarcopenia and muscle, 7(4), 436-48. https://doi.org/10.1002/jcsm.12096
Patel, Mehul S, et al. "Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo." Journal of cachexia, sarcopenia and muscle vol. 7,4 (2016): 436-48. doi: https://doi.org/10.1002/jcsm.12096
Patel MS, Lee J, Baz M, Wells CE, Bloch S, Lewis A, Donaldson AV, Garfield BE, Hopkinson NS, Natanek A, Man WD, Wells DJ, Baker EH, Polkey MI, Kemp PR. Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48. doi: 10.1002/jcsm.12096. Epub 2015 Dec 29. PMID: 27239406; PMCID: PMC4864181.
Copy Download .nbib Format: NLM
Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD.

Journal of cachexia, sarcopenia and muscle

Lewis A, Lee JY, Donaldson AV, Natanek SA, Vaidyanathan S, Man WD, Hopkinson NS, Sayer AA, Patel HP, Cooper C, Syddall H, Polkey MI, Kemp PR.
PMID: 27239417
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):330-44. doi: 10.1002/jcsm.12078. Epub 2016 Jan 05.

BACKGROUND: Loss of muscle mass and strength is a significant comorbidity in patients with chronic obstructive pulmonary disease (COPD) that limits their quality of life and has prognostic implications but does not affect everyone equally. To identify mechanisms that...

Cite
Lewis A, Lee JY, Donaldson AV, et al. Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD. J Cachexia Sarcopenia Muscle. 2016;7(3):330-44doi: 10.1002/jcsm.12078.
Lewis, A., Lee, J. Y., Donaldson, A. V., Natanek, S. A., Vaidyanathan, S., Man, W. D., Hopkinson, N. S., Sayer, A. A., Patel, H. P., Cooper, C., Syddall, H., Polkey, M. I., & Kemp, P. R. (2016). Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD. Journal of cachexia, sarcopenia and muscle, 7(3), 330-44. https://doi.org/10.1002/jcsm.12078
Lewis, Amy, et al. "Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD." Journal of cachexia, sarcopenia and muscle vol. 7,3 (2016): 330-44. doi: https://doi.org/10.1002/jcsm.12078
Lewis A, Lee JY, Donaldson AV, Natanek SA, Vaidyanathan S, Man WD, Hopkinson NS, Sayer AA, Patel HP, Cooper C, Syddall H, Polkey MI, Kemp PR. Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):330-44. doi: 10.1002/jcsm.12078. Epub 2016 Jan 05. PMID: 27239417; PMCID: PMC4863928.
Copy Download .nbib Format: NLM
An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD.

BMJ open respiratory research

Boutou AK, Tanner RJ, Lord VM, Hogg L, Nolan J, Jefford H, Corner EJ, Falzon C, Lee C, Garrod R, Polkey MI, Hopkinson NS.
PMID: 25478193
BMJ Open Respir Res. 2014 Nov 03;1(1):e000051. doi: 10.1136/bmjresp-2014-000051. eCollection 2014.

BACKGROUND: Pulmonary Rehabilitation (PR) is an important treatment for patients with chronic obstructive pulmonary disease (COPD) but it is not established whether any baseline parameter can predict response or compliance.AIM: To identify whether baseline measures can predict who will...

Cite
Boutou AK, Tanner RJ, Lord VM, et al. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Respir Res. 2014;1(1):e000051doi: 10.1136/bmjresp-2014-000051.
Boutou, A. K., Tanner, R. J., Lord, V. M., Hogg, L., Nolan, J., Jefford, H., Corner, E. J., Falzon, C., Lee, C., Garrod, R., Polkey, M. I., & Hopkinson, N. S. (2014). An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ open respiratory research, 1(1), e000051. https://doi.org/10.1136/bmjresp-2014-000051
Boutou, Afroditi K, et al. "An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD." BMJ open respiratory research vol. 1,1 (2014): e000051. doi: https://doi.org/10.1136/bmjresp-2014-000051
Boutou AK, Tanner RJ, Lord VM, Hogg L, Nolan J, Jefford H, Corner EJ, Falzon C, Lee C, Garrod R, Polkey MI, Hopkinson NS. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Respir Res. 2014 Nov 03;1(1):e000051. doi: 10.1136/bmjresp-2014-000051. eCollection 2014. PMID: 25478193; PMCID: PMC4242085.
Copy Download .nbib Format: NLM
Magnetic phrenic nerve stimulation to assess diaphragm function in children following liver transplantation.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies

Rafferty GF, Greenough A, Manczur T, Polkey MI, Harris ML, Heaton ND, Rela M, Moxham J.
PMID: 12797870
Pediatr Crit Care Med. 2001 Apr;2(2):122-126. doi: 10.1097/00130478-200104000-00005.

BACKGROUND: An accurate and practical test of diaphragm function in children in the intensive care unit is desirable. Diaphragm dysfunction can occur after liver transplantation and may be a contributory factor in the respiratory complications after the procedure. OBJECTIVE:...

Cite
Rafferty GF, Greenough A, Manczur T, et al. Magnetic phrenic nerve stimulation to assess diaphragm function in children following liver transplantation. Pediatr Crit Care Med. 2001;2(2):122-126doi: 10.1097/00130478-200104000-00005.
Rafferty, G. F., Greenough, A., Manczur, T., Polkey, M. I., Harris, M. L., Heaton, N. D., Rela, M., & Moxham, J. (2001). Magnetic phrenic nerve stimulation to assess diaphragm function in children following liver transplantation. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2(2), 122-126. https://doi.org/10.1097/00130478-200104000-00005
Rafferty, Gerrard F., et al. "Magnetic phrenic nerve stimulation to assess diaphragm function in children following liver transplantation." Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies vol. 2,2 (2001): 122-126. doi: https://doi.org/10.1097/00130478-200104000-00005
Rafferty GF, Greenough A, Manczur T, Polkey MI, Harris ML, Heaton ND, Rela M, Moxham J. Magnetic phrenic nerve stimulation to assess diaphragm function in children following liver transplantation. Pediatr Crit Care Med. 2001 Apr;2(2):122-126. doi: 10.1097/00130478-200104000-00005. PMID: 12797870.
Copy Download .nbib Format: NLM
Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems.

Chemical engineering journal (Lausanne, Switzerland : 1996)

da Silva D, Kaduri M, Poley M, Adir O, Krinsky N, Shainsky-Roitman J, Schroeder A.
PMID: 31384170
Chem Eng J. 2018 May 15;340:9-14. doi: 10.1016/j.cej.2018.01.010. Epub 2018 Jan 03.

Polylactic acid (PLA) is the most commonly used biodegradable polymer in clinical applications today. Examples range from drug delivery systems, tissue engineering, temporary and long-term implantable devices; constantly expanding to new fields. This is owed greatly to the polymer's...

Cite
da Silva D, Kaduri M, Poley M, et al. Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chem Eng J. 2018;340:9-14doi: 10.1016/j.cej.2018.01.010.
da Silva, D., Kaduri, M., Poley, M., Adir, O., Krinsky, N., Shainsky-Roitman, J., & Schroeder, A. (2018). Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chemical engineering journal (Lausanne, Switzerland : 1996), 3409-14. https://doi.org/10.1016/j.cej.2018.01.010
da Silva, Dana, et al. "Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems." Chemical engineering journal (Lausanne, Switzerland : 1996) vol. 340 (2018): 9-14. doi: https://doi.org/10.1016/j.cej.2018.01.010
da Silva D, Kaduri M, Poley M, Adir O, Krinsky N, Shainsky-Roitman J, Schroeder A. Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems. Chem Eng J. 2018 May 15;340:9-14. doi: 10.1016/j.cej.2018.01.010. Epub 2018 Jan 03. PMID: 31384170; PMCID: PMC6682490.
Copy Download .nbib Format: NLM
Response.

Chest

Polkey MI, Zhong NS, Luo YM.
PMID: 30195368
Chest. 2018 Sep;154(3):733-734. doi: 10.1016/j.chest.2018.07.008.

No abstract available.

Cite
Polkey MI, Zhong NS, Luo YM. Response. Chest. 2018;154(3):733-734doi: 10.1016/j.chest.2018.07.008.
Polkey, M. I., Zhong, N. S., & Luo, Y. M. (2018). Response. Chest, 154(3), 733-734. https://doi.org/10.1016/j.chest.2018.07.008
Polkey, Michael I, et al. "Response." Chest vol. 154,3 (2018): 733-734. doi: https://doi.org/10.1016/j.chest.2018.07.008
Polkey MI, Zhong NS, Luo YM. Response. Chest. 2018 Sep;154(3):733-734. doi: 10.1016/j.chest.2018.07.008. PMID: 30195368.
Copy Download .nbib Format: NLM
Patient symptoms and experience following COVID-19: results from a UK-wide survey.

BMJ open respiratory research

Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A, Cheung C, Walker S, Quint JK, Polkey MI, Hopkinson NS.
PMID: 34732518
BMJ Open Respir Res. 2021 Nov;8(1). doi: 10.1136/bmjresp-2021-001075.

OBJECTIVES: To investigate the experience of people who continue to be unwell after acute COVID-19, often referred to as 'long COVID', both in terms of their symptoms and their interactions with healthcare.DESIGN: We conducted a mixed-methods analysis of responses...

Cite
Buttery S, Philip KEJ, Williams P, et al. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res. 2021;8(1)doi: 10.1136/bmjresp-2021-001075.
Buttery, S., Philip, K. E. J., Williams, P., Fallas, A., West, B., Cumella, A., Cheung, C., Walker, S., Quint, J. K., Polkey, M. I., & Hopkinson, N. S. (2021). Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ open respiratory research, 8(1), . https://doi.org/10.1136/bmjresp-2021-001075
Buttery, Sara, et al. "Patient symptoms and experience following COVID-19: results from a UK-wide survey." BMJ open respiratory research vol. 8,1 (2021). doi: https://doi.org/10.1136/bmjresp-2021-001075
Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A, Cheung C, Walker S, Quint JK, Polkey MI, Hopkinson NS. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res. 2021 Nov;8(1). doi: 10.1136/bmjresp-2021-001075. PMID: 34732518; PMCID: PMC8572361.
Copy Download .nbib Format: NLM
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Carter JM, Polley MC, Leon-Ferre RA, Sinnwell J, Thompson KJ, Wang X, Ma Y, Zahrieh D, Kachergus JM, Solanki M, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Thompson EA, Goetz MP.
PMID: 34108182
Clin Cancer Res. 2021 Oct 15;27(20):5628-5637. doi: 10.1158/1078-0432.CCR-21-0343. Epub 2021 Jun 09.

PURPOSE: Programmed death ligand 1 [PD-(L)1]-targeted therapies have shown modest survival benefit in triple-negative breast cancer (TNBC). PD-L1EXPERIMENTAL DESIGN: From a large cohort of chemotherapy-naïve TNBC, clinicopathologic features, deconvoluted RNA immune signatures, and intraepithelial and stromal TIME (Nanostring GeoMX)...

Cite
Carter JM, Polley MC, Leon-Ferre RA, et al. Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clin Cancer Res. 2021;27(20):5628-5637doi: 10.1158/1078-0432.CCR-21-0343.
Carter, J. M., Polley, M. C., Leon-Ferre, R. A., Sinnwell, J., Thompson, K. J., Wang, X., Ma, Y., Zahrieh, D., Kachergus, J. M., Solanki, M., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K. R., Couch, F. J., Thompson, E. A., & Goetz, M. P. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(20), 5628-5637. https://doi.org/10.1158/1078-0432.CCR-21-0343
Carter, Jodi M, et al. "Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,20 (2021): 5628-5637. doi: https://doi.org/10.1158/1078-0432.CCR-21-0343
Carter JM, Polley MC, Leon-Ferre RA, Sinnwell J, Thompson KJ, Wang X, Ma Y, Zahrieh D, Kachergus JM, Solanki M, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Thompson EA, Goetz MP. Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clin Cancer Res. 2021 Oct 15;27(20):5628-5637. doi: 10.1158/1078-0432.CCR-21-0343. Epub 2021 Jun 09. PMID: 34108182.
Copy Download .nbib Format: NLM
A Flow-assay for Farnesol Removal from Adherent .

Bio-protocol

Polke M, Jacobsen ID.
PMID: 34595247
Bio Protoc. 2017 Oct 05;7(19):e2562. doi: 10.21769/BioProtoc.2562. eCollection 2017 Oct 05.

Here, we describe a protocol for a continuous flow system for

Cite
Polke M, Jacobsen ID. A Flow-assay for Farnesol Removal from Adherent . Bio Protoc. 2017;7(19):e2562doi: 10.21769/BioProtoc.2562.
Polke, M., & Jacobsen, I. D. (2017). A Flow-assay for Farnesol Removal from Adherent . Bio-protocol, 7(19), e2562. https://doi.org/10.21769/BioProtoc.2562
Polke, Melanie, and Jacobsen, Ilse D. "A Flow-assay for Farnesol Removal from Adherent ." Bio-protocol vol. 7,19 (2017): e2562. doi: https://doi.org/10.21769/BioProtoc.2562
Polke M, Jacobsen ID. A Flow-assay for Farnesol Removal from Adherent . Bio Protoc. 2017 Oct 05;7(19):e2562. doi: 10.21769/BioProtoc.2562. eCollection 2017 Oct 05. PMID: 34595247; PMCID: PMC8438493.
Copy Download .nbib Format: NLM
Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey.

BMJ open respiratory research

Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, Renwick L, Ogden L, Quint JK, Johnston SL, Polkey MI, Hopkinson NS.
PMID: 35027428
BMJ Open Respir Res. 2022 Jan;9(1). doi: 10.1136/bmjresp-2021-001056.

INTRODUCTION: The impact of acute COVID-19 on people with asthma appears complex, being moderated by multiple interacting disease-specific, demographic and environmental factors. Research regarding longer-term effects in this group is limited. We aimed to assess impacts of COVID-19 and...

Cite
Philip KEJ, Buttery S, Williams P, et al. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res. 2022;9(1)doi: 10.1136/bmjresp-2021-001056.
Philip, K. E. J., Buttery, S., Williams, P., Vijayakumar, B., Tonkin, J., Cumella, A., Renwick, L., Ogden, L., Quint, J. K., Johnston, S. L., Polkey, M. I., & Hopkinson, N. S. (2022). Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ open respiratory research, 9(1), . https://doi.org/10.1136/bmjresp-2021-001056
Philip, Keir Elmslie James, et al. "Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey." BMJ open respiratory research vol. 9,1 (2022). doi: https://doi.org/10.1136/bmjresp-2021-001056
Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, Renwick L, Ogden L, Quint JK, Johnston SL, Polkey MI, Hopkinson NS. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res. 2022 Jan;9(1). doi: 10.1136/bmjresp-2021-001056. PMID: 35027428.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries